MWM
CLSD

MinichMacGregor Wealth Management’s Clearside Biomedical CLSD Stock Holding History

MinichMacGregor Wealth Management’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-667
Closed -$24K – 70
2020
Q1 		$24K Buy
+667
New +$24.7K 0.02% 80

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

MinichMacGregor Wealth Management's CLSD Position: Q2 2020 in Review

MinichMacGregor Wealth Management sold out of Clearside Biomedical (CLSD) in Q2 2020, closing a stake of 667 shares — an estimated $24K sold.

MinichMacGregor Wealth Management first reported a position in CLSD in Q1 2020 and held it in 1 quarter. The position peaked at $24K in Q1 2020. 45 funds tracked by Wall St. Rank hold CLSD as of Q2 2020.

  • MinichMacGregor Wealth Management reported no remaining Clearside Biomedical position as of Q2 2020 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 667 Clearside Biomedical shares in Q2 2020, an estimated $24K.
  • MinichMacGregor Wealth Management first reported a position in Clearside Biomedical in Q1 2020 and held it in 1 quarter.
  • MinichMacGregor Wealth Management's Clearside Biomedical position peaked at $24K in Q1 2020.
  • 45 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2020.

Based on MinichMacGregor Wealth Management's 13F filing for Q2 2020, filed 5 Aug 2020.